HighGravityDataUnitedHealth Group — Jul 29, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-25-000228
Showing in the filing
Optum Rx revenues
“$151.0 billion to $151.5 billion”
Period
FY2025
Measure
GAAP-tied
Source
Prose
All guidance in this release · 77
Adjusted Net Earnings per Share (a) for FY2025
“At least $16.00”
Revenue Outlook for FY2025
“$445.5 Billion to $448.0 Billion”
Earnings Outlook (Diluted EPS) for FY2025
“at least $14.65 Per Share”
Return to earnings growth for FY2026
“return to earnings growth”
Total Optum Revenues for FY2025
“$266,000 - $267,500”
Eliminations - Revenue for FY2025
“($164,500) - ($165,000)”
Total UnitedHealth Group - Revenue for FY2025
“$445,500 - $448,000”
Diluted Net Earnings per Share for FY2025
“At least $14.65”
Medical cost ratio for FY2025
“89.25% +/- 25 basis points”
Operating cost ratio for FY2025
“12.75% +/- 25 basis points”
Quarterly dividend rate
“$2.21”
Employer & Individual Revenues for FY2025
“$79,600 - $80,100”
Medicare & Retirement Revenues for FY2025
“$170,200 - $170,700”
Community & State Revenues for FY2025
“$94,200 - $94,700”
Total UnitedHealthcare Revenue for FY2025
“$344,000 - $345,500”
UnitedHealthcare - Operating Earnings for FY2025
“$9,000 - $9,300”
UnitedHealthcare Operating Margin for FY2025
“2.6% - 2.7%”
Commercial Risk - Growth in People Served for FY2025
“(385)”
Commercial Risk - Total People Served for FY2025
“8,460”
Commercial Fee - Growth in People Served for FY2025
“720”
Commercial Fee - Total People Served for FY2025
“21,605”
Total Commercial - Growth in People Served for FY2025
“335”
Total Commercial - Total People Served for FY2025
“30,065”
Medicare Advantage - Growth in People Served for FY2025
“650”
Medicare Advantage - Total People Served for FY2025
“8,495”
Standardized Medicare Supplement - Growth in… for FY2025
“(50)”
Standardized Medicare Supplement - Total Peo… for FY2025
“4,285”
Medicaid - Growth in People Served for FY2025
“200”
Medicaid - Total People Served for FY2025
“7,635”
Total Medical - Growth in People Served for FY2025
“1,135”
Total Medical - Total People Served for FY2025
“50,480”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“(300)”
Stand-Alone Part D Prescription Drug Plans -… for FY2025
“2,750”
UnitedHealthcare revenues for FY2025
“$344.0 billion to $345.5 billion”
UnitedHealthcare earnings from operations for FY2025
“$9.0 billion to $9.3 billion”
People served with medical benefits, expecte… for FY2025
“up to 1.135 million”
People served with commercial benefits, expe… for FY2025
“up to 335,000”
Growth within self-funded employer-sponsored… for FY2025
“720,000”
People served with commercial insured offeri… for FY2025
“385,000”
Contraction in individual insured offerings for FY2025
“180,000”
Decline in employer-sponsored group products for FY2025
“205,000”
Medical cost trend in Medicare Advantage off… for FY2025
“~7.5%”
Pricing expectation for Medicare Advantage for FY2025
“just over 5%”
Medicare Advantage medical cost trend accele… for FY2026
“nearly 10%”
Optum Health Operating Earnings for FY2025
“$3,000 - $3,100”
Optum Insight Operating Earnings for FY2025
“$3,550 - $3,650”
Optum Rx Operating Earnings for FY2025
“$6,000 - $6,100”
Optum Eliminations Revenues for FY2025
“($5,100)”
Total Optum Operating Margin for FY2025
“4.7% - 4.8%”
Optum Health Fully Accountable Value-Based C… for FY2025
“5 million”
Optum Insight contract revenue backlog for FY2025
“$32.0 billion”
Optum Rx adjusted scripts for FY2025
“1.67 billion”
Optum Health revenues for FY2025
“$101.1 billion to $101.6 billion”
Optum Health earnings from operations for FY2025
“$3.0 billion to $3.1 billion”
Optum Health operating earnings margin for FY2025
“3.0% to 3.1%”
Optum Health patients served under fully acc… for FY2025
“~300,000 to 5 million”
Optum Insight revenues for FY2025
“$19.0 billion to $19.5 billion”
Optum Insight earnings from operations for FY2025
“$3.55 billion to $3.65 billion”
Optum Insight operating earnings margin for FY2025
“18.2% to 19.2%”
Optum Rx revenues for FY2025
“$151.0 billion to $151.5 billion”
Optum Rx earnings from operations for FY2025
“$6.0 billion to $6.1 billion”
Optum Rx operating margin for FY2025
“4.0%”
Revenues - UnitedHealthcare for FY2025
“344,000 - 345,500”
Revenues - Eliminations for FY2025
“(164,500) - (165,000)”
Total consolidated revenue for FY2025
“$445,500 - $448,000”
Earnings from operations - Optum for FY2025
“$12,550 - $12,850”
Total Optum Operating Earnings for FY2025
“$12,550 - $12,850”
Earnings from operations - UnitedHealthcare for FY2025
“9,000 - 9,300”
Total UnitedHealth Group - Operating Earnings for FY2025
“$21,550 - $22,150”
Investment and other income for FY2025
“~$4,400”
Interest expense for FY2025
“~$4,200”
Depreciation and amortization for FY2025
“~$4,300”
Net earnings attributable to UnitedHealth Gr… for FY2025
“At least $13,350”
Diluted weighted-average shares outstanding for FY2025
“912 - 914”
Operating margin for FY2025
“4.8% - 5.0%”
Tax rate for FY2025
“~18.5%”
Cash flows from operations for FY2025
“~$16,000”
Exhibit 99.1 · the passage around this item
… earlier in the release
Earnings from operations are expected to be $3.55 billion to $3.65 billion. The full year operating earnings margin is estimated at 18.2% to 19.2% and the contract revenue backlog is expected to be $32.0 billion. Optum Rx • Full year 2025 Optum Rx revenues are expected to be $151.0 billion to $151.5 billion compared to $133.2 billion a year ago, with the increase driven by continued strong growth in customers and people served across the company’s integrated pharmacy services offerings. Earnings from operations are expected to be $6.0 billion to $6.1 billion. The full year operating margin is estimated at 4.0% and adjusted scripts are expected to be 1.67 billion. Page 5 of 16 Optum Business Results – Continued Quarterly Financial Performance Three Months Ended June 30, June 30, March 31, 2025 2024 2025 Revenues $67.2 billion $62.9 billion $63.9 billion Earnings from Operations $3.1 billion $3.9 billion $3.9 billion Operating Margin 4.6% 6.2% 6.1% Optum Health • Optum Health’s second quarter 2025 revenue of $25.2 billion decreased $1.8 billion or 7% year-over-year, driven by the legacy customer contract revisions cited in first quarter 2025 and effects related to the Medicare Advantage funding cuts. • Second quarter earnings from operations were $636 million compared to $1.9 billion in the year ago quarter and operating margins were 2.5% and 7.1%, respectively. The decline was due to higher medical care activity, the flow through effects from underpriced health plan offerings where th
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.